Table 1. Demographic data of the Dutch and Spanish cohort.
Dutch cohort | Spanish cohort | |||||
Cases | Controls | Cases | Controls | |||
= Ototoxicity | = No ototoxicity | = Ototoxicity | = No ototoxicity | |||
N = 42 | N = 68 | p-value | N = 16 | N = 22 | p-value | |
Age at diagnosis (y) | 15 | 15 | 0.82 | 11.5 | 14 | 0.23 |
median, range | (5–40) | (7–39.3) | (4–29) | (7–28) | ||
Gender (male) | 22 | 33 | 0.6 | 15 | 6 | 0.1 |
N, % | (40%) | (60%) | (71.4%) | (28.6%) | ||
Cumulative dose cisplatin (mg/m2) | 500 | 480 | 1 | 504 | 515 | 0.32 |
median, range | (100–600) | (200–600) | (120–870) | (140–720) | ||
Concomitant drugs | ||||||
Vincristine (N, %) | 3 (2.7%) | 2 (1.8%) | 0.3 | 2 (5.2%) | 4 (10.5%) | 0.13 |
Aminoglyocide antibiotics (N, %) | 0 | 0 | 15 (68.2%) | 10 (62.5%) | 0.74 | |
Otoprotectants (N, %) | 0 | 0 | 0 | 0 |